Merck, the manufacturer of painkiller Vioxx, has settled deceptive advertising charges for $58 million and agreed to submit all new television commercials for its drugs to the Food and Drug Administration for review for the next seven years. The agency had challenged Merck’s direct-to-consumer television ads, which began in 1999.
Related Posts
Graphic artist finds inspiration in European signage
On a recent trip to Italy, seasoned graphic artist Elizabeth Goodspeed developed a fascination with overseas signage. Entranced…
Change Healthcare suffers $1.6 billion loss from cyberattack
Change Healthcare, a subsidiary of UnitedHealth Group, stands to lose approximately $1.6 billion as a result of a…
Cey Adams’ enduring impact on hip-hop aesthetics
Cey Adams, highly recognized in the graphic design and hip-hop industry, has left an enduring mark on the…